55 related articles for article (PubMed ID: 10930294)
1. Differential glycosylation of two glycoproteins synthesized by murine B cells in response to IL-4 plus IL-5.
Chintalacharuvu SR; Emancipator SN
Cytokine; 2000 Aug; 12(8):1182-8. PubMed ID: 10930294
[TBL] [Abstract][Full Text] [Related]
2. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines.
Chintalacharuvu SR; Emancipator SN
J Immunol; 1997 Sep; 159(5):2327-33. PubMed ID: 9278322
[TBL] [Abstract][Full Text] [Related]
3. Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA.
Kunimoto DY; Harriman GR; Strober W
J Immunol; 1988 Aug; 141(3):713-20. PubMed ID: 2456329
[TBL] [Abstract][Full Text] [Related]
4. Effects of combinations of cytokines on murine antigen-specific B lymphocytes.
Vogel L; Pike BL
Cell Immunol; 1993 Oct; 151(2):414-24. PubMed ID: 8402946
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation is not required for membrane localization or secretion of IgM in a mouse B cell lymphoma.
Sibley CH; Wagner RA
J Immunol; 1981 May; 126(5):1868-73. PubMed ID: 6783700
[TBL] [Abstract][Full Text] [Related]
6. Th2 induction by Nippostrongylus secreted antigens in mice deficient in B cells, eosinophils or MHC Class I-related receptors.
Holland MJ; Harcus YM; Balic A; Maizels RM
Immunol Lett; 2005 Jan; 96(1):93-101. PubMed ID: 15585312
[TBL] [Abstract][Full Text] [Related]
7. Requirement of 8-mercaptoguanosine as a costimulus for IL-4-dependent mu to gamma1 class switch recombination in CD38-activated B cells.
Tsukamoto Y; Uehara S; Mizoguchi C; Sato A; Horikawa K; Takatsu K
Biochem Biophys Res Commun; 2005 Oct; 336(2):625-33. PubMed ID: 16143305
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells.
Matsumoto R; Matsumoto M; Mita S; Hitoshi Y; Ando M; Araki S; Yamaguchi N; Tominaga A; Takatsu K
Immunology; 1989 Jan; 66(1):32-8. PubMed ID: 15493259
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
10. Cross-linking of MHC class II molecules with anti-MHC class II antibody or epitope peptide prevents resting B lymphocyte differentiation by inhibiting NF-kappaB-dependent gene expression.
Kim J; Kim HR; Bae JL; Kim DH; Ki HJ; Lee HK; Choi SH; Jang YS
Mol Cells; 2001 Aug; 12(1):67-76. PubMed ID: 11561732
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
Ouyang GF; Saio M; Suwa T; Imai H; Nakagawa J; Nonaka K; Umemura N; Kijima M; Takami T
Int J Oncol; 2006 May; 28(5):1201-8. PubMed ID: 16596236
[TBL] [Abstract][Full Text] [Related]
12. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice.
Tanaka K; Yamamoto T; Aikawa Y; Kizawa K; Muramoto K; Matsuno H; Muraguchi A
Rheumatology (Oxford); 2003 Nov; 42(11):1365-71. PubMed ID: 12810927
[TBL] [Abstract][Full Text] [Related]
14. IL-21 ensures TGF-beta 1-induced IgA isotype expression in mouse Peyer's patches.
Seo GY; Youn J; Kim PH
J Leukoc Biol; 2009 May; 85(5):744-50. PubMed ID: 19168593
[TBL] [Abstract][Full Text] [Related]
15. Early activation markers of human peripheral dendritic cells.
Hellman P; Eriksson H
Hum Immunol; 2007 May; 68(5):324-33. PubMed ID: 17462499
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of murine B cells induced by chondroitin sulfate B.
Yoshihara R; Aoyama E; Kadota Y; Kawai S; Goto T; Zhong M; Gohda E
Cell Immunol; 2007; 250(1-2):14-23. PubMed ID: 18206137
[TBL] [Abstract][Full Text] [Related]
17. Redundant and unique regulation of activated mouse B lymphocytes by IL-4 and IL-21.
Jin H; Malek TR
J Leukoc Biol; 2006 Dec; 80(6):1416-23. PubMed ID: 16943384
[TBL] [Abstract][Full Text] [Related]
18. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 5 in the link between the innate and acquired immune response.
Takatsu K; Kouro T; Nagai Y
Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]